LB Pharmaceuticals Inc <LBRX.O>: BMO raises target price to $54 from $46
LBRX•Related News
Local Bounti Q2 FY26 net loss narrows 8.15% to 19.82 million; sales rise 14% to 13.85 million
LOCL•
Dollar ticks up on Iran tension, with US data in focus
TLT•
WeRide 2Q FY26 loss narrows 1.4% YoY to RMB 400.7 million; revenue rises 82.2% YoY to RMB 231.7 million
WRD•
SUNation Q2 FY26 net loss narrows 65% to $3.34 million; revenue drops 37.5% to $8.2 million
SUNE•
Madison Square Garden Entertainment Q4 Revenue USD 196.3 Million Vs. IBES Estimate USD 166.6 Million
MSGE•